Antisense antibacterial method and composition
AssigneeAVI BioPharma, Inc.
InventorPatrick L. Iversen
Life of this patent
Estimating the term…
Abstract
The invention relates to compositions comprising oligomers antisense to bacterial 16S or 23S rRNA and capable of selectively modulating the biological activity thereof, and methods for their use. More particularly, the invention relates to antisense oligomers directed to 16S or 23S rRNA found in one or more particular bacteria, or generally conserved among bacteria in general, and to pharmaceutical compositions and methods of treatment comprising the same.
Claims6
A method of inhibiting growth of bacteria selected from the group consisting of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecium, and Salmonella typhimurium, comprising
- contacting said bacteria in vitro with an effective amount of an antisense morpholino oligomer containing from 10 to 40 nucleotide subunits, each of said subunits comprising a morpholino ring supporting a base-pairing moiety effective to bind by Watson-Crick base pairing to a respective nucleotide base, said base-pairing moieties including a targeting nucleic acid sequence at least 10 nucleotides in length which is complementary to a 16S or 23S rRNA nucleic acid sequence of said bacteria, wherein adjacent subunits are joined by uncharged phosphorodiamidate linkages.
Dependencies are inferred from the claim text.